PAXLOVID is a medicine that is available under EUA for the treatment of

mild-to-moderate COVID-19 in adults and children 12 years of age and older weighing

at least 88 pounds (40 kg) who are at high risk for progression to severe COVID-19,

including hospitalization or death. Although PAXLOVID is FDA-approved for the

treatment of COVID-19 in certain adults (see section What other treatment choices

are there?), PAXLOVID use in children remains investigational because it is still being

studied. There is limited information about the safety and effectiveness of using

PAXLOVID to treat children with mild-to-moderate COVID-19.